Radionuclide Scintigraphy in Metabolic Bone Disease

Gary J.R. Cook*, Gopinath Gnanasegaran, Ignac Fogelman

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

2 Citations (Scopus)

Abstract

Radionuclide bone imaging remains the most widely used method for detection of benign and metastatic involvement of the skeleton. This chapter talks about the applications of radionuclide scintigraphy in bone metastases, osteoporosis, Paget's disease, hyperparathyroidism, renal osteodystrophy, and osteomalacia. Recent advances in hybrid anatomical/functional imaging consolidates the roles of radioisotope imaging in skeletal disease. In particular, hybrid single photon emission computed tomography (SPECT)/CT provides an opportunity to more accurately assess specific clinical problems, such as persistent back pain in osteoporotic patients.

Original languageEnglish
Title of host publicationPrimer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
Subtitle of host publicationEighth Edition
PublisherWILEY-BLACKWELL
Pages283-288
Number of pages6
ISBN (Electronic)9781118453926
ISBN (Print)9781118453889
DOIs
Publication statusPublished - 19 Jul 2013

Keywords

  • Metabolic bone diseases
  • Radionuclide scintigraphy
  • Single photon emission computed tomography (SPECT)

Fingerprint

Dive into the research topics of 'Radionuclide Scintigraphy in Metabolic Bone Disease'. Together they form a unique fingerprint.

Cite this